Enlivex Therapeutics Ltd. Stock
Enlivex Therapeutics Ltd. dominated the market today, gaining €0.040 (3.170%).
Our community identified positive and negative aspects for Enlivex Therapeutics Ltd. stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Enlivex Therapeutics Ltd. stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Enlivex Therapeutics Ltd. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enlivex Therapeutics Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enlivex Therapeutics Ltd. | 3.170% | -9.353% | -0.787% | -49.600% | -43.750% | -83.636% | - |
| Oramed Pharmaceuticals | -2.830% | -4.633% | 0.142% | -48.817% | 0.189% | -76.881% | -23.438% |
| Galmed Pharmaceuticals Ltd. | -2.150% | 1.087% | 5.682% | -92.017% | -14.679% | - | - |
| Evolus Inc | -1.630% | 4.237% | 16.038% | 36.667% | 35.912% | 72.028% | - |